Monoclonal Antibodies Against Breast Cancer
The application of classical hybridoma technology to the study of human mammary carcinoma resulted in the generation of a variety of monoclonal antibodies that identify several antigens associated with this type of tumor (1–3). Monoclonal reagents with selected specificities are therefore available in increasing number, and their potential for applications in the diagnosis and characterization of breast cancer is under investigation.
KeywordsLobular Carcinoma Bone Marrow Sample Primary Breast Carcinoma Human Mammary Carcinoma Ductal Carcinoma Cell
Unable to display preview. Download preview PDF.
- 7.Horan-Hand P., Nuti M., Colcher D., Schlom J.: Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor associated antigens. Cancer Res., 43: 728 (1983).Google Scholar
- 8.Colnaghi M.I., Clemente C., Della Porta G., Della Torre G., Mariani-Costantini R., Mènard S., Rilke F., Tagliabue E.: Monoclonal antibodies to human breast cancer. In “Monoclonal Antibodies ‘82” - Elsevier Press, 1982.Google Scholar